Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications.

Eitemau Tebyg

• Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
  gan: Dourish, C, et al.
  Cyhoeddwyd: (1989)
• The cholecystokinin receptor antagonist devazepide enhances morphine-induced analgesia but not morphine-induced respiratory depression in the squirrel monkey.
  gan: Dourish, C, et al.
  Cyhoeddwyd: (1990)
• Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.
  gan: Dourish, C, et al.
  Cyhoeddwyd: (1988)
• Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.
  gan: Dourish, C, et al.
  Cyhoeddwyd: (1989)
• Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
  gan: O'Neill, M, et al.
  Cyhoeddwyd: (1991)